Trade Mark Journal No.2026/002 9 January 2026

UK00004311835 17 December 2025 (5)

INKORZA

Class 5: Pharmaceuticals for human use, namely, pharmaceutical preparations for treatment of cancer; pharmaceuticals for human use, namely, pharmaceutical preparations for treatment of oncological diseases, disorders, and conditions.

AbbVie Inc.

Representative: Carpmaels & Ransford LLP